Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
Clinical practices, at least the very best of them, take place out in the open. If anything, these depend on the expertise and input from several groups like academics, clinicians, healthcare organizations, manufacturers of medicines and medical technology, and even patient organizations. These collaborations, however, need to be transparent, and for this particular purpose, the […]
The 17th Annual Pharma and Medical Device Compliance Congress was held at the Mandarin Hotel in Washington, D.C from the 19th to the 21st of October, 2016. The conference provided an excellent opportunity for senior representatives from the compliance, legal, transparency, legal affairs, commercial operations/marketing, and regulatory affairs industries to network and discuss operational best […]
With the government taking a more proactive approach to mining Open Payments data to evaluate, investigate, and detect cases of healthcare fraud, pharmaceutical companies are even more keen to proactively stamp out any suspicion of fraud proactively, and they are turning to analytics techniques to do so. No pharma company wants to find out second […]
The 4th Annual Pharma Compliance Europe Congress was held at the Royal Garden Hotel, London, UK, on the 5th and 6th of October, 2016. The conference provided an excellent opportunity for senior representatives from the compliance, legal, transparency, legal affairs, commercial operations/marketing, and regulatory affairs industries to network and discuss operational best practices. Attendees of […]
The largest nursing home pharmacy in the United States of America, based on the number of beds served, Omnicare, has agreed to pay $28.1 million as a means of settling charges of violating the FCA and Anti-kickback statute alleged against it. It was alleged that Omnicare requested and accepted received kickbacks from Abbott Laboratories. In […]
Physicians have long been receiving payments from drug and device manufacturers all over the country. If anything, these transactions cover anything and everything from meals to royalties and even speaking fees. To put it in simple words, this is a billion-dollar relationship that the public finally got to take a look at thanks to the […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use